Domain Therapeutics
Founded 2008 · 36 employees on LinkedIn · 2 known investors
Domain Therapeutics develops drug discovery and development therapies that target GPCRs to modulate the immune system, focusing on immuno-oncology and inflammatory diseases.
Investors · 2
Frequently asked questions
- What does Domain Therapeutics do?
- Domain Therapeutics develops drug discovery and development therapies that target GPCRs to modulate the immune system, focusing on immuno-oncology and inflammatory diseases.
- Who are Domain Therapeutics's investors?
- Domain Therapeutics's investors include 3B Future Health Fund, CTI Life Sciences Fund L.P..